The group of autoimmune liver diseases includes AIH (autoimmune hepatitis), PBC (Primary Biliary Cirrhosis), and PSC (Primary Sclerosing Cholangitis), each with different markers. IFT detects these markers based on the principle of immunofluorescence, enabling simultaneous detection of multiple markers and helping differentiate between autoimmune diseases with high sensitivity.


